NFKB1 and neoplasm: Alongside TNF-α, IL-6 contributes significantly to amplifying NF-κB-driven inflammation by activating the JAK/STAT3 pathway, which can subsequently boost NF-κB signaling (84, 85) This establishes another positive feedback loop that sustains chronic inflammation and supports tumor growth.